RECOMBITEK C4/CVThis page contains information on RECOMBITEK C4/CV for veterinary use.
The information provided typically includes the following:
- RECOMBITEK C4/CV Indications
- Warnings and cautions for RECOMBITEK C4/CV
- Direction and dosage information for RECOMBITEK C4/CV
RECOMBITEK C4/CVThis treatment applies to the following species:
Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine
Modified Live Virus, Canarypox Vector
DESCRIPTION: RECOMBITEK® C4/CV contains a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus; modified live adenovirus type 2, parainfluenza virus, parvovirus, and coronavirus; plus sterile water diluent. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible dogs.
INDICATIONS: RECOMBITEK® C4/CV is recommended for the vaccination of healthy dogs 6 weeks of age and older for prevention of disease due to canine distemper virus, canine parvovirus, canine coronavirus, canine adenovirus type 1 (canine hepatitis), canine adenovirus type 2 (canine respiratory disease complex), and canine parainfluenza virus.
DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy dogs. For primary vaccination, revaccinate with a second 1 mL dose 2 to 3 weeks later. Dogs younger than 12 weeks of age should be revaccinated with a single 1 mL dose every 2 to 3 weeks, the last dose given at or over 12 weeks of age. Revaccinate annually with a single 1 mL dose.
PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn container and all unused contents. Contains gentamicin as a preservative. It is generally recommended to avoid vaccination of pregnant dogs. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Transient lethargy, as well as pain and swelling at the site of injection, may occur following use of this product. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine, as directed by a veterinarian.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
RECOMBITEK is a registered trademark of MERIAL.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
Distributed in Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 4B6
25 x 1 Dose, Lyophilized
25 x 1 mL, Sterile Water
NAC No.: 11110624
Merial is now part of Boehringer Ingelheim
3239 SATELLITE BLVD., DULUTH, GA, 30096
|Every effort has been made to ensure the accuracy of the RECOMBITEK C4/CV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-05-31